To view this, you need to install the Flash Player 5. Please go to here and download it.

Personal Injury Blog

Actos Defendant has found some of its missing documents

October 20, 2014 @ 12:25 PM — by Jim Pettit
Tagged with:
The defendant manufacturer in the Actos litigation, Takeda Pharmaceutical, has very recently advised the federal court in Louisiana that it has now found over 61,000 e-mails and attachments consisting of more than 330,000 pages. Takeda had previously been sanctioned by the court for spoliation of documents for 46 of its custodians of records. Indeed, attorneys for plaintiffs have been permitted by the court to tell the jury about Takeda's spoliation of this evidence. Locks Law Firm LLC represents patients who took Actos for their Type-2 diabetes and who subsequently developed bladder cancer.  Those cases were filed in federal court in New Jersey and were transferred to the federal multi-district litigation ("MDL") and so are being managed by Judge Rebecca Doherty in the Western District of Louisiana. If you or a loved one developed bladder cancer after using Actos, please contact Locks Law Firm today.  Our Pennsylvania, New Jersey and New York attorneys c

So-called tort reform does not decrease costs or reduce testing ordered by doctors

October 16, 2014 @ 04:47 PM — by Jim Pettit
The forces behind so-called tort reform (more accurately named tort deform) argue that tort reform legislation will save consumers money because doctors will not have to perform what is erroneously called 'defensive medicine" (that is, ordering tests so the doctor does not get sued). A study presented in the prestigious New England Journal of Medicine (October 16, 2014) shows that in three (3) so-called tort reform states, emergency room doctors basically ordered the same tests as before. There was no reduction in costs. Another inference one could reasonably draw from this study is that most doctors probably do not indulge in so-called "defensive medicine" in order not to be sued,  but rather most doctors probably order testing for the benefit of their patients.

Actos Verdict for Plaintiff

October 08, 2014 @ 10:49 AM — by Jim Pettit
Tagged with:

A jury in Philadelphia found defendant, Takeda, liable for over $2 million for failing to warn that its drug, Actos, can cause bladder cancer, and for causing a 79-year-old woman's bladder cancer. During the three-week-plus trial,  Takeda had argued that smoking or other causes were to blame. There have now been seven (7) trials involving claims that Actos caused bladder cancer. The largest verdict, $9 billion earlier this year, is being appealed by Takeda. Two verdicts in favor of plaintiffs (California and Maryland) which combined totalled $8.2 million, were overturned by the trial judge. Three verdicts (two in Las Vegas and one in Illinois) were defense verdicts in favor of Takeda. Evidence shows that Takeda officials destroyed documents about Actos. Actos is a Type-2 diabetes drug which  has generated over $16 billion in sales since it was released in 1999. 

Fungal Meningitis Lawsuit Filed

September 24, 2014 @ 04:31 PM — by Jim Pettit
Tagged with:
Locks Law Firm LLC has filed suit for a patient who received a fungal-contaminated steroid injection in his spine, causing fungal meningitis. The steroid product came from New England Compounding Center ("NECC") in Massachusetts. Federal officials shut down NECC in 2012 because NECC was producing lots of methylprednisolone acetate (MPA) which were contaminated. The Center for Disease Control (CDC) states the contaminated steroids caused 64 deaths and hundreds of patients were caused to have meningitis. Approximately 45 cases have been filed in New Jersey and many more have been filed around the country. There are about 300 cases in the federal Multidistrict Litigation (MDL). 

Johnson & Johnson withdrawing surgical tool that can spread cancer in women

August 01, 2014 @ 10:08 AM — by Admin

On Wednesday, July 30th, Johnson & Johnson announced it was withdrawing a surgical tool that can spread cancer in women.  This voluntary recall removed the devices made by the largest manufacturer of those devices from the market amid a contentious debate over its use.

The company planned to tell customers world-wide in a letter to return the devices known as laparoscopic power morcellators. J&J already suspended sales of new morcellators in April after the U.S. Food and Drug Administration advised doctors not to use the tool, which slices up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery. In April, J&J defended the safety of the tool but said it was waiting for more guidance from the medical community.

FDA to Require Blood Clot Warnings on Testosterone Products

June 23, 2014 @ 09:19 AM — by Admin

On June 20, 2014 the United States Food and Drug Administration announced that it would require the manufacturers of all approved testosterone products to include a warning in the drug labeling about the risk of blood clots in the veins, also known as venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). See the FDA announcement here (

...The Locks Law Firm is actively investigating cases of stroke, heart attack, blood clots in the veins, pulmonary embolism and death in users of testosterone products, especially those prescribed for what is known as "low-T syndrome." If you, a friend or a loved one has used a testosterone gel, cream, patch or other testosterone formulation and suffered any of the conditions mentioned above, please contact the Locks Law Firm.

Jerry Lindheim on the Afternoon Drive show on WPHT 1210AM regarding Nursing Home Abuse

April 10, 2014 @ 04:29 PM — by Admin
Tagged with:

On the 21st day of March,  Jerry Lindheim, Esquire-partner at the Locks Law Firm was featured on the Dick Morris Afternoon Drive radio broadcast WPHT 1210AM during which time he discussed nursing home neglect and abuse and patient's rights and remedies.

Risperdal Cases

February 28, 2014 @ 12:11 PM — by Leon Carpenter
Tagged with: Risperdal

Locks Law Firm announces it is now accepting Risperdal cases.

Zimmer Durom Cup Hip Replacement Cases

February 28, 2014 @ 12:04 PM — by Leon Carpenter

Locks Law Firm announces it is now accepting Zimmer Durom cup hip replacement cases.

Locks Law Firm announces it is handling claims against the manufacturers and distributors of testosterone-based products

February 09, 2014 @ 08:27 PM — by Leon Carpenter

Last week the U.S. Food and Drug Administration said it has begun investigating the risk of stroke, heart attack and death in men taking prescription testosterone drugs.

The announcement came on the heels of two recent two studies that suggested an increased risk of heart attacks in men who take testosterone, a hormone produced in the testicles that is responsible for maintaining muscle bulk, bone growth and sexual function, the FDA said. The FDA said it has not concluded that testosterone increases the risk of cardiac events but said it is issuing an alert "while we continue to evaluate the information from these studies and other available data."

Share |

Back to top